Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Presenter: Hélène Eltchaninoff

August 31, 2024

Presentation ESC 2024

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Presenter: Volker Rudolph

August 31, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Advertisement

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Trial Challenges Continuation of Oral Anticoagulants During TAVI

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Continuation versus Interruption of Oral Anticoagulation during TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content